Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
Format:	Article
Sprog:	Russian
Udgivet:	LLC "Publishing House OKI" 2024-06-01
Serier:	Антибиотики и Химиотерапия
Fag:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
Online adgang:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

Lignende værker

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
af: M. M. Baranova, et al.
Udgivet: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
af: D. V. Bukhanova, et al.
Udgivet: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
af: Alyssa Howren, et al.
Udgivet: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
af: Matthew Carroll, et al.
Udgivet: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
af: Svedbom A, et al.
Udgivet: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
af: Zlatković-Švenda Mirjana, et al.
Udgivet: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
af: Hermine Leroi, et al.
Udgivet: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
af: I Z Gaydukova, et al.
Udgivet: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
af: Takacs P, et al.
Udgivet: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
af: Joshua L. Lee, et al.
Udgivet: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
af: M. M. Baranova, et al.
Udgivet: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
af: M. Rossini, et al.
Udgivet: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
af: Taras S. Panevin, et al.
Udgivet: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
af: I. Pantano, et al.
Udgivet: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
af: Milena Iwaszko, et al.
Udgivet: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
af: Viola Sacchi, et al.
Udgivet: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
af: Krzysztof Bonek, et al.
Udgivet: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
af: Santhi Mantravadi, et al.
Udgivet: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
af: Philip Brenner, et al.
Udgivet: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
af: E. E. Gubar, et al.
Udgivet: (2023-08-01)

Nod-like receptors in inflammatory arthritis
af: Sahib Singh Madahar, et al.
Udgivet: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
af: Xinlin Nie, et al.
Udgivet: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
af: M. Elaine Husni, et al.
Udgivet: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
af: Christian Dejaco, et al.
Udgivet: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
af: D. V. Bukhanova, et al.
Udgivet: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
af: Eleonora Alina Dragomir-Lica, et al.
Udgivet: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
af: Hanna Park, et al.
Udgivet: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
af: Acar M, et al.
Udgivet: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
af: Yu. V. Muravyev, et al.
Udgivet: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
af: Noemí Martínez-López de Castro, et al.
Udgivet: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
af: Sotaro Nakajima, et al.
Udgivet: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
af: Andrea Picchianti-Diamanti, et al.
Udgivet: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
af: Giovanni Cioffi, et al.
Udgivet: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
af: I. Z. Gaidukova, et al.
Udgivet: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
af: Zlatković-Švenda Mirjana I., et al.
Udgivet: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
af: R. M. Balabanova, et al.
Udgivet: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
af: Muhammad Haroon, et al.
Udgivet: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
af: Jaroslaw Nowakowski, et al.
Udgivet: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
af: Tacjana Anna Barczyńska, et al.
Udgivet: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
af: T. V. Dubinina, et al.
Udgivet: (2023-02-01)